test sequence Search Results


targeted exome analysis xomedx slice  (GeneDx Inc)
90
GeneDx Inc targeted exome analysis xomedx slice
Targeted Exome Analysis Xomedx Slice, supplied by GeneDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/trio+whole+exome+sequencing+xomedxplus+test/pm25541840-45-9-12
Average 90 stars, based on 1 article reviews
targeted exome analysis xomedx slice - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
duration pattern test (dpt)  (Auditec Inc)
90
Auditec Inc duration pattern test (dpt)
Duration Pattern Test (Dpt), supplied by Auditec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/duration+pattern+sequence+test++dps+/pmc11813184-139-29-18
Average 90 stars, based on 1 article reviews
duration pattern test (dpt) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
skat-o test (optimal sequence kernel association test)  (RStudio)
90
RStudio skat-o test (optimal sequence kernel association test)
Skat O Test (Optimal Sequence Kernel Association Test), supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/skat+o+test++optimal+sequence+kernel+association+test+/pmc06489684-125-5-13
Average 90 stars, based on 1 article reviews
skat-o test (optimal sequence kernel association test) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
next-generation sequency-based gene panel test ngs—custom panel enrichment  (Nextera AS)
90
Nextera AS next-generation sequency-based gene panel test ngs—custom panel enrichment
Next Generation Sequency Based Gene Panel Test Ngs—Custom Panel Enrichment, supplied by Nextera AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/next+generation+sequency+based+gene+panel+test+ngs+custom+panel+enrichment/pmc09406511-70-7-14
Average 90 stars, based on 1 article reviews
next-generation sequency-based gene panel test ngs—custom panel enrichment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
toxnav tm germline dna sequencing-based test  (Oxford Cancer Biomarkers)
90
Oxford Cancer Biomarkers toxnav tm germline dna sequencing-based test
Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the <t> ToxNav </t> test
Toxnav Tm Germline Dna Sequencing Based Test, supplied by Oxford Cancer Biomarkers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/toxnav+tm+germline+dna+sequencing+based+test/pmc06797583-173-7-0
Average 90 stars, based on 1 article reviews
toxnav tm germline dna sequencing-based test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
germline tp53 genetic testing  (FALCO Biosystems Ltd)
90
FALCO Biosystems Ltd germline tp53 genetic testing
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Germline Tp53 Genetic Testing, supplied by FALCO Biosystems Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/tp53+target+sequencing+test/pmc11249967-56-22-26
Average 90 stars, based on 1 article reviews
germline tp53 genetic testing - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
saliva based test for braca1 gene sequence  (Color Genomics)
90
Color Genomics saliva based test for braca1 gene sequence
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Saliva Based Test For Braca1 Gene Sequence, supplied by Color Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/saliva+based+test+for+braca1+gene+sequence/us12038434-681-5-17
Average 90 stars, based on 1 article reviews
saliva based test for braca1 gene sequence - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
frequency pattern test (fpt) auditec version  (Auditec Inc)
90
Auditec Inc frequency pattern test (fpt) auditec version
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Frequency Pattern Test (Fpt) Auditec Version, supplied by Auditec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/pitch+pattern+sequence+test/pm33237189-101-1-5
Average 90 stars, based on 1 article reviews
frequency pattern test (fpt) auditec version - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
screening test with next generation sequence including 19 genes and 154 variants  (BML Inc)
90
BML Inc screening test with next generation sequence including 19 genes and 154 variants
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Screening Test With Next Generation Sequence Including 19 Genes And 154 Variants, supplied by BML Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/screening+test+with+next+generation+sequence+including+19+genes+and+154+variants/pmc10448821-41-24-26
Average 90 stars, based on 1 article reviews
screening test with next generation sequence including 19 genes and 154 variants - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
wltp charge depleting test sequence for two plug-in hybrid electric vehicles  (Joint Research Center)
90
Joint Research Center wltp charge depleting test sequence for two plug-in hybrid electric vehicles
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Wltp Charge Depleting Test Sequence For Two Plug In Hybrid Electric Vehicles, supplied by Joint Research Center, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/wltp+charge+depleting+test+sequence+for+two+plug+in+hybrid+electric+vehicles/10__3390_slash_su12145747-192-7-16
Average 90 stars, based on 1 article reviews
wltp charge depleting test sequence for two plug-in hybrid electric vehicles - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
chi-sequence test  (CH Instruments)
90
CH Instruments chi-sequence test
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Chi Sequence Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/chi+sequence+test/pmc08835724-54-27-27
Average 90 stars, based on 1 article reviews
chi-sequence test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
nextstepdx plus sequencing-based test  (Lineagen Inc)
90
Lineagen Inc nextstepdx plus sequencing-based test
2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis
Nextstepdx Plus Sequencing Based Test, supplied by Lineagen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/test+sequence/nextstepdx+plus+sequencing+based+test/pmc05201278__pone__0169064__s003-67-1-0
Average 90 stars, based on 1 article reviews
nextstepdx plus sequencing-based test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the ToxNav test

Journal: Cancer Medicine

Article Title: ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study

doi: 10.1002/cam4.2529

Figure Lengend Snippet: Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the ToxNav test

Article Snippet: Oxford Cancer Biomarkers Limited (OxfordBio) developed the ToxNav TM germline DNA sequencing‐based test.

Techniques: Sequencing

Germline variants analyzed in the ToxNav test and frequencies observed in the PRECISE clinical cohort

Journal: Cancer Medicine

Article Title: ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study

doi: 10.1002/cam4.2529

Figure Lengend Snippet: Germline variants analyzed in the ToxNav test and frequencies observed in the PRECISE clinical cohort

Article Snippet: Oxford Cancer Biomarkers Limited (OxfordBio) developed the ToxNav TM germline DNA sequencing‐based test.

Techniques: Variant Assay

2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis

Journal: Juntendo Medical Journal

Article Title: Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance System

doi: 10.14789/jmj.JMJ22-0012-CR

Figure Lengend Snippet: 2015 version of Chompret's criteria for Li-Fraumeni syndrome diagnosis

Article Snippet: However, since the patient met Chompret's criteria (2015, ) with multiple cancers and early-onset breast cancer in the ‘core' tumors, we performed germline TP53 genetic testing (FALCO Ltd., Kyoto, Japan), with her consent (written informed consent was obtained from the patient.).

Techniques:

Pathological features of the surgical specimens a) and c) right breast cancer; b) and d) left breast cancer. a-b) hematoxylin and eosin staining ×100; b-d) p53 staining x100.

Journal: Juntendo Medical Journal

Article Title: Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance System

doi: 10.14789/jmj.JMJ22-0012-CR

Figure Lengend Snippet: Pathological features of the surgical specimens a) and c) right breast cancer; b) and d) left breast cancer. a-b) hematoxylin and eosin staining ×100; b-d) p53 staining x100.

Article Snippet: However, since the patient met Chompret's criteria (2015, ) with multiple cancers and early-onset breast cancer in the ‘core' tumors, we performed germline TP53 genetic testing (FALCO Ltd., Kyoto, Japan), with her consent (written informed consent was obtained from the patient.).

Techniques: Staining

Consensus recommendations for the management of Li-Fraumeni syndrome <xref ref-type= 12) " width="100%" height="100%">

Journal: Juntendo Medical Journal

Article Title: Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance System

doi: 10.14789/jmj.JMJ22-0012-CR

Figure Lengend Snippet: Consensus recommendations for the management of Li-Fraumeni syndrome 12)

Article Snippet: However, since the patient met Chompret's criteria (2015, ) with multiple cancers and early-onset breast cancer in the ‘core' tumors, we performed germline TP53 genetic testing (FALCO Ltd., Kyoto, Japan), with her consent (written informed consent was obtained from the patient.).

Techniques: Diagnostic Assay, Imaging

Comparison between previous reports and this case with c.216dupC in TP53 (p.Val73Arg fsX76)

Journal: Juntendo Medical Journal

Article Title: Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance System

doi: 10.14789/jmj.JMJ22-0012-CR

Figure Lengend Snippet: Comparison between previous reports and this case with c.216dupC in TP53 (p.Val73Arg fsX76)

Article Snippet: However, since the patient met Chompret's criteria (2015, ) with multiple cancers and early-onset breast cancer in the ‘core' tumors, we performed germline TP53 genetic testing (FALCO Ltd., Kyoto, Japan), with her consent (written informed consent was obtained from the patient.).

Techniques: Comparison

Toronto protocol: agreed surveillance recommendations for TP53 carriers <xref ref-type= 13) " width="100%" height="100%">

Journal: Juntendo Medical Journal

Article Title: Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance System

doi: 10.14789/jmj.JMJ22-0012-CR

Figure Lengend Snippet: Toronto protocol: agreed surveillance recommendations for TP53 carriers 13)

Article Snippet: However, since the patient met Chompret's criteria (2015, ) with multiple cancers and early-onset breast cancer in the ‘core' tumors, we performed germline TP53 genetic testing (FALCO Ltd., Kyoto, Japan), with her consent (written informed consent was obtained from the patient.).

Techniques: